Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Yoshihiro, Isomura"'
Autor:
Osamu Toyoshima, Shuntaro Yoshida, Toshihiro Nishizawa, Tadahiro Yamakawa, Toru Arano, Yoshihiro Isomura, Takamitsu Kanazawa, Hidehiko Ando, Yosuke Tsuji, Kazuhiko Koike
Publikováno v:
Endoscopy International Open, Vol 09, Iss 07, Pp E1032-E1038 (2021)
Background and study aims High-quality endoscopy requires improvement of not only the adenoma detection rate (ADR) but also the serrated polyp (SP) detection rate and the mean number of adenomas per positive procedure (MAP +). We evaluated whether a
Externí odkaz:
https://doaj.org/article/0d243293b90243c2ab48cac54f5041fe
Autor:
Takafumi Sugimoto, Yutaka Yamaji, Kosuke Sakitani, Yoshihiro Isomura, Shuntaro Yoshida, Atsuo Yamada, Yoshihiro Hirata, Keiji Ogura, Makoto Okamoto, Kazuhiko Koike
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 29, Iss 6, Pp 321-325 (2015)
BACKGROUND: Endoscopic submucosal dissection (ESD) of early gastric cancer is a minimally invasive procedure. However, the risk for metachronous cancers after successful cancer treatment remains high and the risk factors for metachronous cancers have
Externí odkaz:
https://doaj.org/article/72f571d1abf643ae91010f265433505c
Autor:
Kazuhiko Koike, Shuntaro Yoshida, Yoshihiro Isomura, Osamu Toyoshima, Yosuke Tsuji, Takamitsu Kanazawa, Toru Arano, Hidehiko Ando, Tadahiro Yamakawa, Toshihiro Nishizawa
Publikováno v:
Endoscopy International Open, Vol 09, Iss 07, Pp E1032-E1038 (2021)
Endoscopy International Open
Endoscopy International Open
Background and study aims High-quality endoscopy requires improvement of not only the adenoma detection rate (ADR) but also the serrated polyp (SP) detection rate and the mean number of adenomas per positive procedure (MAP +). We evaluated whether a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e666d662a42f8cb342d2c60961c35a4d
http://www.thieme-connect.de/DOI/DOI?10.1055/a-1393-5469
http://www.thieme-connect.de/DOI/DOI?10.1055/a-1393-5469
Autor:
Makoto Okamoto, Tomoya Omae, Keigo Matsuo, Nobumi Suzuki, Kazuhiko Koike, Yoshihiro Hirata, Takafumi Sugimoto, Yoku Hayakawa, Goichi Togo, Ryota Niikura, Satoki Shichijo, Noriyuki Takano, Keisuke Fukui, Hirobumi Suzuki, Hirotsugu Watabe, Motoko Seto, Shinzo Yamamoto, Satoshi Mochizuki, Yuri Ito, Atsuo Yamada, Yoshihiro Isomura
Publikováno v:
Journal of Digestive Diseases. 17:670-675
Objective Vonoprazan is a potassium-competitive acid blocker, a new type of acid-suppressing drug, and has recently become available for peptic ulcers, gastroesophageal reflux disease, and Helicobacter pylori (H. pylori) eradication. Its efficacy for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e932ad516830ce967c074ca4721a225e
https://doi.org/10.1111/1751-2980.12398
https://doi.org/10.1111/1751-2980.12398
Autor:
Yoshihiro Isomura, Hiroto Kinoshita, Takanori Kanai, Hidekazu Suzuki, Toshihiro Nishizawa, Akira Toyoshima, Naohisa Yahagi, Osamu Toyoshima, Ai Fujimoto, Shuntaro Yoshida
Publikováno v:
Journal of Clinical Biochemistry and Nutrition. 60:208-210
The effects of patient age on the efficacy of eradication treatment for Helicobacter pylori (H. pylori) remain unclear. The present study aimed to determine whether age affects eradication therapy involving vonoprazan, a novel potassium-competitive a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2570461b1954fa901b8bb902ffc1c47
https://doi.org/10.3164/jcbn.16-86
https://doi.org/10.3164/jcbn.16-86
Autor:
Takahisa Sato, Yoji Suzuki, Hiroyuki Amano, Yuko Miura, Kenji Hosoda, Toshihiro Kawai, Hiroshi Ohyama, Y. Kondo, Keiko Nakagomi, Yuta Tokudome, Masao Omata, Hitoshi Mochizuki, Hiroshi Ashizawa, Yoshihiro Isomura, Yuichiro Kojima, Shuntaro Obi, Miho Kanda, Shinpei Sato
Publikováno v:
Hepatology international. 13(2)
Lenvatinib (an inhibitor of vascular endothelial growth factor (GF) receptors 1–3, fibroblast GF receptors 1–4, platelet-derived GF receptor α, rearranged during transfection, and stem cell factor receptor) was non-inferior to sorafenib in a pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a02e85d72a23e7ab2e426e739a94c094
https://pubmed.ncbi.nlm.nih.gov/30671808
https://pubmed.ncbi.nlm.nih.gov/30671808
Autor:
Junko Fujisaki, Kosuke Sakitani, Shuntaro Yoshida, Yutaka Saito, Osamu Toyoshima, Hidenobu Watanabe, Daisuke Ohki, Kazuhiko Koike, Akira Toyoshima, Hiroharu Yamashita, Naohisa Yahagi, Masahide Arita, Toshihiro Nishizawa, Yoshihiro Isomura, Toshiro Iizuka, Yosuke Kataoka
Publikováno v:
Helicobacter
Background Helicobacter pylori eradication therapy is commonly performed to reduce the incidence of gastric cancer. However, gastric cancer is occasionally discovered even after successful eradication therapy. Therefore, we examined the prognosis of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ede1d1e111dc4a6a3e3ad0823d66f1f
http://europepmc.org/articles/PMC6055630
http://europepmc.org/articles/PMC6055630
Autor:
Yoshihiro Isomura, Shuntaro Yoshida, Kazuhiko Koike, Yutaka Yamaji, Makoto Okamoto, Kosuke Sakitani, Atsuo Yamada, Yoshihiro Hirata, Takafumi Sugimoto, Keiji Ogura
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 29, Iss 6, Pp 321-325 (2015)
BACKGROUND: Endoscopic submucosal dissection (ESD) of early gastric cancer is a minimally invasive procedure. However, the risk for metachronous cancers after successful cancer treatment remains high and the risk factors for metachronous cancers have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cef37b04d3ac808ef312a53b08b1117
https://doi.org/10.1155/2015/950734
https://doi.org/10.1155/2015/950734
Autor:
Kazuhiko Koike, Yoshihiro Isomura, Yoshihiro Hirata, Atsuo Yamada, Yutaka Yamaji, Shuntaro Yoshida
Publikováno v:
Journal of Digestive Diseases. 15:469-476
Objective We investigated whether the prokinetic activity of mosapride, a 5-hydroxytryptamine 4 receptor agonist, in combination with proton pump inhibitor (PPI) would ameliorate symptoms of gastroesophageal reflux disease (GERD) in Japanese patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9a9cd4945d84f230e67f247f76418cb
https://doi.org/10.1111/1751-2980.12167
https://doi.org/10.1111/1751-2980.12167
Autor:
Satoki, Shichijo, Yoshihiro, Hirata, Ryota, Niikura, Yoku, Hayakawa, Atsuo, Yamada, Satoshi, Mochizuki, Keigo, Matsuo, Yoshihiro, Isomura, Motoko, Seto, Nobumi, Suzuki, Hirobumi, Suzuki, Shinzo, Yamamoto, Takafumi, Sugimoto, Tomoya, Omae, Makoto, Okamoto, Hirotsugu, Watabe, Goichi, Togo, Noriyuki, Takano, Keisuke, Fukui, Yuri, Ito, Kazuhiko, Koike
Publikováno v:
Journal of digestive diseases. 17(10)
Vonoprazan is a potassium-competitive acid blocker, a new type of acid-suppressing drug, and has recently become available for peptic ulcers, gastroesophageal reflux disease, and Helicobacter pylori (H. pylori) eradication. Its efficacy for H. pylori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ef73d1aa9bf7cc94c3ce1b712cc19304
https://pubmed.ncbi.nlm.nih.gov/27534444
https://pubmed.ncbi.nlm.nih.gov/27534444